Abstract
Evans syndrome is a rare disorder characterized by combined autoimmune thrombocytopenia (ITP) and autoimmune hemolytic anemia (AIHA). Standard treatments consist of transfusions, corticosteroids, splenectomy, IVIG, anabolic steroids, vincristine, alkylating agents, or cyclosporine. In a patient with refractory disease, an allogeneic hematopoietic stem cell transplant (HSCT) resulted in complete clinical and serologic remission for more than 30 months. Allogeneic HSCT may be the only current curative therapy for Evans syndrome but may also be complicated by significant toxicities. Bone Marrow Transplantation (2001) 28, 903–905.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Savasan S, Warrier I, Ravindranath Y . The spectrum of Evans' syndrome Arch Dis Child 1997 77: 245–248
Portielje JEA, Westendorp RGJ, Kluin-Nelemans HC, Brand A . Morbidity and mortality in adults with idiopathic thrombocytopenic purpura Blood 2001 97: 2549–2554
Stasi R, Stipa E, Masi M et al. Long-term observation of 208 adults with chronic idiopathic thrombocytopenic purpura Am J Med 1995 89: 436–442
Ng SC . Evans syndrome: a report on 12 patients Clin Lab Haematol 1992 14: 189–193
Mathew P, Chen G, Wang W . Evans syndrome: results of a national survey J Pediatr Hematol/Oncol 1997 19: 433–437
Wang WC . Evans syndrome in childhood: pathophysiology, clinical course, and treatment Am J Ped Hematol/Oncol 1998 10: 330–338
Shvidel L, Shtarlid M, Klepfish A et al. Evans syndrome complicating fludarabine treatment for advanced B-CLL Br J Haematol 1997 99: 706
Wang W, Herrod H, Pui CH et al. Immunoregulatory abnormalities in Evans syndrome Am J Hematol 1983 15: 381–390
Brodsky RA, Petri M, Smith BD et al. Immunoablative high-dose cyclophosphamide without stem cell rescue for refractory, severe autoimmune disease Ann Intern Med 1998 129: 1031–1035
Martino R, Sureda A, Brunet S . Peripheral blood stem cell mobilization in refractory autoimmune Evans syndrome: a cautionary case report Bone Marrow Transplant 1997 20: 521
Musso M, Porretto F, Crescimanno A et al. Autologous peripheral blood stem and progenitor (CD34+) cell transplantation for systemic lupus erythematosus complicated by Evans syndrome Lupus 1998 7: 492–494
Skoda RC, Tichelli A, Tyndall A et al. Autologous peripheral blood stem cell transplantation in a patient with chronic autoimmune thrombocytopenia Br J Haematol 1997 99: 56–57
Marmont AM, van Lint MT, Occhini D et al. Failure of autologous stem cell transplantation in refractory thrombocytopenic purpura Bone Marrow Transplant 1998 22: 827–828
Lim SH, Kell J, Al-Sabah A et al. Peripheral blood stem cell transplantation for refractory autoimmune thrombocytopenic purpura Lancet 1997 349: 475
Demirer T, Celebi H, Arat M et al. Autoimmune thrombocytopenia in a patient with small cell lung cancer developing after chemotherapy and resolving autologous peripheral blood stem cell transplantation Bone Marrow Transplant 1999 24: 335–337
Huhn RD, Read EJ, Rick M et al. Intensive immunosuppression with high-dose cyclophosphamide and autologous CD34+ selected hematopoietic cell support for chronic refractory autoimmune thrombocytopenia (interim report) Blood 1998 92: (Suppl.) 178 (Abstr. 719)
Pillard C, Kanold J, Halle P et al. Two-step immunoablative treatment with autologous peripheral blood CD34+ cell transplantation in an 8-year-old boy with autoimmune haemolytic anaemia Br J Haematol 2000 110: 900–902
Jindra P, Koza V, Fiser J et al. Autologous CD34+ cell transplantation after FAMP treatment in patient with CLL and persisting AIHA: complete remission of lymphoma with control of autoimmune complications Bone Marrow Transplant 1999 24: 215–217
Raetz E, Beatty PG, Adams RH . Treatment of severe Evans syndrome with an allogeneic cord blood transplant Bone Marrow Transplant 1997 20: 427–429
De Stefano P, Zecca M, Giorgiani G et al. Resolution of immune hemolytic anaemia with allogeneic bone marrow transplantation after unsuccessful autograft Br J Haematol 1999 106: 1063–1064
Muller BU, Tichelli A, Passweg JR et al. Successful treatment of refractory acquired pure red cell aplasia (PRCA) by allogenic bone marrow transplantation Bone Marrow Transplant 1999 23: 1205–1207
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Oyama, Y., Papadopoulos, E., Miranda, M. et al. Allogeneic stem cell transplantation for Evans syndrome. Bone Marrow Transplant 28, 903–905 (2001). https://doi.org/10.1038/sj.bmt.1703237
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1703237
Keywords
This article is cited by
-
Nonmyeloablative allogeneic bone marrow transplantation of a child with systemic autoimmune disease and lung vasculitis
Immunologic Research (2008)
-
Allogeneic haematopoietic stem cell transplantation for severe autoimmune diseases: great expectations but controversial evidence
Bone Marrow Transplantation (2006)
-
Split chimerism may be enough to cure Evans syndrome
Bone Marrow Transplantation (2006)
-
Treatment of severe autoimmune disease by stem-cell transplantation
Nature (2005)
-
Nonmyeloablative allogeneic bone marrow transplantation for treatment of childhood overlap syndrome and small vessel vasculitis
Bone Marrow Transplantation (2004)